BeOne Medicines AG (6160.HK) HKSE

Currency In HKD

BeOne Medicines AG

Address

Aeschengraben 27

Basel, BL 4051

Switzerland

Phone

41 61 685 19 00

Website

https://beonemedicines.com

Sector

Healthcare

Industry

Biotechnology

Employees

12000

First IPO Date

August 08, 2018

Key Executives

Name	Title	Pay	Year Born
John V. Oyler	Co-Founder, Executive Chairman & Chief Executive Officer	23.09M	1968
Chan Lee	General Counsel, Senior VP & Corporate Secretary	9.85M	1968
Aaron Rosenberg	Chief Financial Officer	9.94M	1977
Wang Lai	President and Global Head of Research & Development	10.35M	1977
Xiaodong Wang	Co-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder	33.34M	1963
Eleanor Duff	Senior Vice President & Head of Corporate Communications	0	N/A
Liza Heapes	Head of Investor Relations	0	N/A
Titus Ball	Vice President & Chief Accounting Officer	0	1974
Graham Hardiman	Global Head of Human Resources	0	N/A
Marcello Damiani	Chief Technology Officer	0	1970
Xiang Guo	Senior Vice President of Global Statistics & Data Science	0	N/A
Kyu-Sung Lee	Senior VP and Global Head of Technical Operations & Manufacturing	0	N/A
Luo Lusong	Head of External Innovation & Senior Vice President	0	N/A
Mark Lanasa	Senior Vice President & Chief Medical Officer for Solid Tumors	0	N/A

Description

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.